Homans Elizabeth 4
4 · Lyell Immunopharma, Inc. · Filed Sep 14, 2021
Insider Transaction Report
Form 4
Homans Elizabeth
DirectorChief Executive Officer
Transactions
- Award
Option (right to buy)
2021-09-13+1,370,469→ 1,370,469 totalExercise: $16.05Exp: 2031-09-12→ Common Stock (1,370,469 underlying)
Footnotes (1)
- [F1]The shares vest in equal monthly installments over the forty-eight months following September 13, 2021.